Iron supplements concomitant with HIF-PHIs in the treatment of CKD anemia

• Main Authors: Xue Wang (Author), Cuiting Wei (Author), Delong Zhao (Author), Xuefeng Sun (Author), Fengge Zhu (Author), Yan Mei (Author), Qian Ma (Author), Guangyan Cai (Author), Xiangmei Chen (Author), Ping Li (Author)
• Format: Book
• Published: Karger Publishers, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Anemia is a common and important complication in patients with chronic kidney disease (CKD). Accordingly, the current treatment is based on erythropoiesis stimulating agents (ESAs) and iron. Hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD) inhibitors (HIF-PHIs) have been developed to t...